Scoop has an Ethical Paywall
Work smarter with a Pro licence Learn More
Top Scoops

Book Reviews | Gordon Campbell | Scoop News | Wellington Scoop | Community Scoop | Search

 

NZ Says No To Funding Hugely Expensive Cancer Drug

NZ Says No To Funding Hugely Expensive Cancer Drug

Pharmac spokeswoman Dr Dilky Rasiah today fronted a media conference in Wellington explaining that alleged cancer wonder drug Herceptin would not be funded.
*******

Funding for the alleged cancer wonder drug Herceptin - the drug that was earlier this year the subject of intense media hoopla - today ran into a brick wall.

At a media briefing in Wellington Pharmac spokeswoman Dr Dilky Rasiah explained that there was insufficient clinical data to justify a positive funding decision.

The door remains open to funding Herceptin, but this would require better data, she says.

When asked by Scoop how a drug company could justify the enormous price tag for a course of Herceptin treatment (between 70K and 100K), when the data fails to justify a positive outcome from Pharmac, DHB spokesperson David Meates explained that high price drugs need good backing data.

"The back up data becomes even more critical [in the case of Herceptin] - with that size of investment we need to be absolutely on solid ground that it is going to give us the health gains and the health improvements we are looking for," he said.

Listen to Pharmac spokesperson Dr Dilky Rasiah and DHB spokesperson David Meates explain the decision not to fund Herceptin and later take questions from the media

Advertisement - scroll to continue reading

Are you getting our free newsletter?

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.

Scoop Audio.Scoop Streaming Audio: PHARMAC media briefing on non-funding of Herceptin


Click here to download file (mp3)

ENDS

© Scoop Media

Advertisement - scroll to continue reading
 
 
 
Top Scoops Headlines

 
 
 
 
 
 
 
 
 
 
 

Join Our Free Newsletter

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.